In humans, TNF-α has been implicated in the physiopathology of autoimmune diseases and consequently anti-TNF-α treatments (antibodies or soluble receptor) have been used with successful results obtained in Crohn’s disease and rheumatoid arthritis (Chan and Carter, 2010). Here, TNF is linked to Crohn disease.